Can a new drug tame inflammatory diseases by calming immune cells?
NCT ID NCT07745751
First seen Aug 04, 2026 · Last updated Aug 07, 2026 · Updated 3 times
Summary
This early-stage trial is testing an investigational drug called TRT-448 in healthy adults to see if it is safe and well-tolerated. The drug works by modulating immune cells and could one day be used to treat inflammatory diseases. Participants receive either the drug or a placebo, and researchers monitor for side effects and how the drug behaves in the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TRT-448, an investigational drug that modulates immune cells for the treatment of inflammatory disease
- What this could lead to
- If successful, this could pave the way for a new treatment option for inflammatory diseases by targeting immune cells.
- What could go wrong
- This is an early-phase trial focused on safety in healthy volunteers, so it may not work as intended or could have unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY AND TOLERABILITY IN HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.